pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$OGNOrganon & Co.

$OGN13.72+0.07%
Jersey City, NJ, USupdated 1d ago

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

SEC EDGAR ↗Yahoo Finance ↗
community read0 votes

🐶 often sniffed alongside

top 8
  • tagRecall2 co-mentions · 2 sources
  • drugNOXAFIL POWDERMIX KIT2 co-mentions · 1 sources
  • drugNOXAFIL2 co-mentions · 1 sources
  • drugHADLIMA2 co-mentions · 1 sources
  • tagSmall Molecule1 co-mentions · 1 sources
  • drugHUMIRA1 co-mentions · 1 sources
  • drugPOSACONAZOLE1 co-mentions · 1 sources
  • drugposaconazole DR1 co-mentions · 1 sources
pipeline
9
marketed
4
phase 3
0
catalysts ytd
13
approvals ytd
10
recalls ytd
0

Pipeline(9)

pipeline depth9 products
Marketed: 4Unknown: 5
4Marketed5Unknown
Marketed
(betamethasone acetate + betamethasone sodium phosphate)
Cerebral Edema
Marketed
(desloratadine + pseudoephedrine sulfate) ER
Nasal Congestion
Marketed
PROSCAR
3-oxo-5-alpha-steroid 4-dehydrogenase 2
Marketed
tocilizumab biosimilar
Coronavirus Disease 2019 (COVID-19)
drug
FOSAMAX
1 INDICATIONS AND USAGE FOSAMAX PLUS D is a combination o…
Farnesyl pyrophosphate synthase
drug
FOSAMAX PLUS D
1 INDICATIONS AND USAGE FOSAMAX PLUS D is a combination o…
Farnesyl pyrophosphate synthase
drug
IMPLANON
HIV infection
Progesterone receptor
drug
SINEMET
INDICATIONS AND USAGE SINEMET is indicated in the treatme…
Aromatic-L-amino-acid decarboxylase
drug
SINEMET CR
Familial dysautonomia
Aromatic-L-amino-acid decarboxylase

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

earnings (1)
Jul 31, 2026
earnings
$OGN13.72+0.07%
2mo ago
Organon & Co. earnings
Organon & Co.
→
view all catalysts →
🐶 Hiring Signal
No open roles indexed yet — view Organon & Co. jobs →

News

no news has mentioned this company yet
identifiers
ticker
$OGN
SEC CIK
0001821825
country
US
source
sec_tickers
top tags
Cardiology2Dermatology2Immunology2Infectious Disease2Pulmonology2
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 3m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?